Unichem Laboratories receives ANDA approval for its Amiodarone Tablets

Unichem Laboratories Limited has received ANDA approval for its Amiodarone Tablets, USP, 200 mg from the United States Food and Drug Administration (USFDA) to market a generic version of CORDARONE® (amiodarone) tablets of Wyeth Pharmaceuticals Inc.

Amiodarone tablets are indicated for the treatment of documented, life-threatening recurrent ventricular fibrillation and life-threatening recurrent hemodynamically unstable tachycardia in adults who have not responded to adequate doses of other available antiarrhythmics or when alternative agents cannot be tolerated. The product will be commercialized from Unichem's Ghaziabad Plant.

Shares of UNICHEM LABORATORIES LTD. was last trading in BSE at Rs.210.45 as compared to the previous close of Rs. 202.45. The total number of shares traded during the day was 31263 in over 2828 trades.

The stock hit an intraday high of Rs. 213.1 and intraday low of 204.05. The net turnover during the day was Rs. 6548845.

Source : Equity Bulls

Keywords